Commitments by the biopharmaceutical industry to clinical trials transparency: the evolving environment
S. Baronikova, J. Purvis, E. Southam, J. Beeso, C. Winchester, A. Panayi
This study evaluates data disclosure commitments and rates among top biopharmaceutical companies and non-industry sponsors, finding higher disclosure rates among industry sponsors.
bioRxiv · Nov 12, 2018Scientific Communication & Education